MwanzoGBM • FRA
add
Inovio Pharmaceuticals Inc
Bei iliyotangulia
€ 3.80
Bei za siku
€ 3.85 - € 3.85
Bei za mwaka
€ 3.69 - € 12.14
Thamani ya kampuni katika soko
107.75M USD
Wastani wa hisa zilizouzwa
105.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 27.35M | 175.54% |
Mapato halisi | -25.17M | 25.83% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.89 | 42.95% |
EBITDA | -26.93M | -10.37% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 84.80M | -49.36% |
Jumla ya mali | 107.06M | -44.56% |
Jumla ya dhima | 33.52M | -38.99% |
Jumla ya hisa | 73.54M | — |
hisa zilizosalia | 26.10M | — |
Uwiano wa bei na thamani | 1.35 | — |
Faida inayotokana na mali | -56.77% | — |
Faida inayotokana mtaji | -69.87% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -25.17M | 25.83% |
Pesa kutokana na shughuli | -27.44M | 5.73% |
Pesa kutokana na uwekezaji | 14.08M | 356.25% |
Pesa kutokana na ufadhili | elfu 660.65 | -5.44% |
Mabadiliko halisi ya pesa taslimu | -12.70M | 62.53% |
Mtiririko huru wa pesa | -17.47M | 10.73% |
Kuhusu
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1999
Tovuti
Wafanyakazi
127
